FOXP3 and neoplasm: Analysis of specific surface markers of Tregs [GITR, HLA-DR, CD45RO, CD152, and CD45RA and FOXP3] also showed that there is a steady increase in the number of Tregs in both peripheral blood and tumor microenvironment (116).